Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Chondrosarcoma | 1 | 2017 | 24 | 0.70 | Why? |
| Tracheal Neoplasms | 1 | 2017 | 16 | 0.70 | Why? |
| Sarcoidosis | 1 | 2021 | 271 | 0.67 | Why? |
| Fibrosis | 1 | 2020 | 800 | 0.64 | Why? |
| Hemoptysis | 1 | 2017 | 172 | 0.56 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.36 | Why? |
| Palliative Care | 1 | 2017 | 2665 | 0.23 | Why? |
| Pulmonary Fibrosis | 2 | 2021 | 1068 | 0.21 | Why? |
| Lung Neoplasms | 1 | 2017 | 3228 | 0.20 | Why? |
| Collagen | 1 | 2021 | 222 | 0.20 | Why? |
| Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3832 | 0.20 | Why? |
| Bronchoscopy | 2 | 2017 | 991 | 0.19 | Why? |
| Silicones | 1 | 2017 | 26 | 0.18 | Why? |
| Fatal Outcome | 2 | 2017 | 3438 | 0.17 | Why? |
| Radiopharmaceuticals | 1 | 2021 | 763 | 0.15 | Why? |
| Positron-Emission Tomography | 1 | 2021 | 802 | 0.15 | Why? |
| Autopsy | 3 | 2021 | 3495 | 0.14 | Why? |
| Embolization, Therapeutic | 1 | 2017 | 269 | 0.13 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2021 | 1153 | 0.13 | Why? |
| Radiology, Interventional | 1 | 2017 | 398 | 0.12 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2021 | 2309 | 0.12 | Why? |
| Leukocyte Count | 1 | 2021 | 3178 | 0.11 | Why? |
| Continuity of Patient Care | 1 | 2020 | 1574 | 0.10 | Why? |
| Stents | 1 | 2017 | 916 | 0.10 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.10 | Why? |
| Tomography, X-Ray Computed | 3 | 2021 | 25144 | 0.09 | Why? |
| Italy | 7 | 2021 | 38444 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Machine Learning | 1 | 2020 | 4395 | 0.07 | Why? |
| Dyspnea | 1 | 2017 | 3847 | 0.07 | Why? |
| Cough | 1 | 2017 | 4891 | 0.06 | Why? |
| Diagnosis, Differential | 1 | 2017 | 7220 | 0.06 | Why? |
| Breast Neoplasms | 1 | 2020 | 3633 | 0.06 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.05 | Why? |
| Triage | 1 | 2020 | 7151 | 0.05 | Why? |
| Aged | 7 | 2021 | 215776 | 0.05 | Why? |
| Hospital Mortality | 2 | 2020 | 22087 | 0.05 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.05 | Why? |
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 9335 | 0.05 | Why? |
| Humans | 14 | 2021 | 930598 | 0.04 | Why? |
| Disease Progression | 1 | 2017 | 13580 | 0.04 | Why? |
| Breast | 1 | 2020 | 290 | 0.04 | Why? |
| Female | 9 | 2021 | 380317 | 0.04 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.04 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.04 | Why? |
| Male | 8 | 2021 | 367725 | 0.04 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2021 | 243684 | 0.04 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Respiratory Insufficiency | 1 | 2017 | 7301 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Decision Support Systems, Clinical | 1 | 2020 | 551 | 0.04 | Why? |
| Belgium | 1 | 2020 | 2064 | 0.03 | Why? |
| Medical Oncology | 2 | 2020 | 3826 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.03 | Why? |
| Area Under Curve | 1 | 2020 | 2564 | 0.03 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.03 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Pandemics | 7 | 2020 | 389249 | 0.02 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.02 | Why? |
| Macrophages | 1 | 2021 | 2784 | 0.02 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Survivors | 1 | 2021 | 2619 | 0.02 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Lymphocytes | 1 | 2021 | 3056 | 0.02 | Why? |
| Antimalarials | 1 | 2020 | 2505 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Outpatients | 1 | 2020 | 3417 | 0.02 | Why? |
| Survival Analysis | 1 | 2020 | 7592 | 0.02 | Why? |
| Cause of Death | 1 | 2020 | 4823 | 0.02 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2020 | 9537 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| China | 2 | 2020 | 50654 | 0.02 | Why? |
| Sex Factors | 1 | 2020 | 11014 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.02 | Why? |
| Adult | 4 | 2021 | 244371 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
Barisione's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(97)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(137)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_